{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:34:47Z","timestamp":1760189687870,"version":"3.44.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1053\/j.semnuclmed.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T00:50:21Z","timestamp":1563583821000},"page":"411-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Update on Serum Glucose and Metabolic Management of Clinical Nuclear Medicine Studies: Current Status and Proposed Future Directions"],"prefix":"10.1053","volume":"49","author":[{"given":"Arif","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Anolik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan H.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0001","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jacr.2018.09.006","article-title":"Management of diabetes mellitus before 18F-fluorodeoxyglucose PET\/CT: A nationwide patient-centered assessment of approaches to examination preparation","volume":"16","author":"Kaiser","year":"2019","journal-title":"J Am Coll Radiol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0002","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.smj.0000209366.91803.99","article-title":"Perioperative glucose control in the diabetic or nondiabetic patient","volume":"99","author":"Smiley","year":"2006","journal-title":"South Med J"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0003","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"Sulfonylureas and their use in clinical practice","volume":"11","author":"Sola","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0004","doi-asserted-by":"crossref","first-page":"936","DOI":"10.5114\/aoms.2013.34991","article-title":"The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus","volume":"9","author":"Guardado-Mendoza","year":"2013","journal-title":"Arch Med Sci"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0005","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2019.06.001_bib0006","first-page":"S173","article-title":"American Diabetes Association Position Statement Diabetes care in the hospital: Standards of Medical Care in Diabetes \u2013 2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/dia.2011.0118","article-title":"Pharmacology of intravenous insulin administration: Implications for future closed-loop glycemic control by the intravenous\/intravenous route","volume":"14","author":"Skjaervold","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0008","first-page":"161","article-title":"Insulin half-life and utilization in normal pregnancy","volume":"43","author":"Burt","year":"1974","journal-title":"Obstetr Gynecol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2016.0101","article-title":"Minimization of hypoglycemia as an adverse event during insulin infusion: Further refinement of the yale protocol","volume":"18","author":"Marvin","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0010","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"Van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1932296817750899","article-title":"Comparison of computer-guided versus standard insulin infusion regimens in patients with diabetic ketoacidosis","volume":"12","author":"Ullal","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0012","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11892-016-0772-0","article-title":"Review of insulin-dosing formulas for continuous subcutaneous insulin infusion (CSII) for adults with type 1 diabetes","volume":"16","author":"King","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0013","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.2337\/dci15-0002","article-title":"Technosphere inhaled insulin: is faster better?","volume":"38","author":"Leahy","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0014","first-page":"237","article-title":"Statistically based CSII parameters: Correction factor, CF (1700 rule), carbohydrate-to-insulin ratio, CIR (2.8 rule), and basal-to-total ratio","volume":"3","author":"Davidson","year":"2003","journal-title":"Diabetes Technol Ther"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0015","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1177\/193229681000400516","article-title":"Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels","volume":"4","author":"Walsh","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0016","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0017","series-title":"Clinical Diabetes \u2013 Translating Research into Practice\/Vivian A. Fonseca","article-title":"Insulin-sensitizing and insulin sparing drugs: Thiazolidinediones and metformin","author":"Jabbour","year":"2006"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0018","first-page":"885","article-title":"Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0","volume":"47","author":"Delbeke","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0019","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes","volume":"20","author":"Soccio","year":"2014","journal-title":"Cell Metabolism"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/openhrt-2015-000327","article-title":"Acarbose: Safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outomes","volume":"2","author":"DiNicolantonio","year":"2015","journal-title":"Open Heart"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0021","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/dc09-2009","article-title":"Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes","volume":"33","author":"Gaziano","year":"2010","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"10.1053\/j.semnuclmed.2019.06.001_bib0022","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.2337\/dc11-s237","article-title":"Bile acid sequestrants in the treatment of type 2 diabetes","volume":"34","author":"Handelsman","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0023","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.2337\/dc18-1091","article-title":"Control of postprandial hyperglycemia in type 1 diabetes by 24-hour fixed-dose coadministration of pramlintide and regular human insulin: A randomized, two-way crossover study","volume":"41","author":"Riddle","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0024","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: Version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"journal-title":"Rev","article-title":"American College of Radiology and Society of Pediatric Radiology practice guidelines ACR\u2013SPR practice parameter for performing FDG-PET\/CT in oncology","year":"2016","key":"10.1053\/j.semnuclmed.2019.06.001_bib0025"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0026","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2967\/jnumed.112.112524","article-title":"EANM\/SNMMI Guideline for 18F-FDG Use in inflammation and infection","volume":"54","author":"Jamar","year":"2013","journal-title":"J Nucl Med"},{"journal-title":"Rev","article-title":"American College of Radiology and Society of Pediatric Radiology practice guidelines ACR\u2013SPR practice parameter for the performance of scintigraphy for inflammation and infection","year":"2018","key":"10.1053\/j.semnuclmed.2019.06.001_bib0027"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0028","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: Joint procedural recommendation of the EANM, SNMMI, the PET Interest Group (PIG), and endorsed by the ASNC","volume":"45","author":"Slart","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0029","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/RLU.0000000000001827","article-title":"ACR\u2013SPR\u2013STR practice parameter for the performance of cardiac positron emission tomography \u2013 computed tomography (PET\/CT) imaging","volume":"42","author":"Subramaniam","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0031","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00259-005-1779-y","article-title":"EANM\/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology","volume":"32","author":"Hesse","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0032","unstructured":"Waxman AD, Herholz K, Lewis DH, et al: Society of nuclear medicine procedure guideline for FDG PET brain imaging version 1.0"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0033","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2967\/jnumed.106.039065","article-title":"Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue","volume":"48","author":"Baba","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0034","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11307-006-0064-1","article-title":"Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18] fluoro-D-glucose injection following I.V. insulin in diabetic patients","volume":"8","author":"Turcotte","year":"2006","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MNM.0b013e32835d1034","article-title":"Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing 18F-FDG PET\/CT","volume":"34","author":"Caobelli","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0036","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2967\/jnumed.108.056283","article-title":"Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients","volume":"50","author":"Roy","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0037","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNM.0000000000000082","article-title":"Influence of subcutaneous administration of rapid-acting insulin in the quality of 18F-FDG PET\/CT studies","volume":"35","author":"Garcia","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0038","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MNM.0b013e32836066a2","article-title":"Ultrashort-acting insulin may improve on 18F-FDG PET\/CT image quality in patients with uncontrolled diabetic mellitus","volume":"34","author":"Song","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0039","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.rlu.0000257273.55996.8b","article-title":"No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine","volume":"32","author":"Niederkohr","year":"2007","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0040","series-title":"Paper presented at: 2012 Mid-Winter Meeting of the Society of Nuclear Medicine and Molecular Imaging; January 26\u201329","article-title":"The effect of peroxisome proliferator-activated receptor-g (PPAR-\u03b3) agonists on [18F]-fluorodeoxyglucose(18-F FDG)uptake","author":"Berenji","year":"2012"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0041","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13550-015-0128-9","article-title":"A phase II clinical trial to investigate the effect of pioglitazone on 18F-FDG uptake in malignant lesions","volume":"5","author":"Han","year":"2015","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0042","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","article-title":"High and typical 18F-FDG bowel uptake in patients treated with metformin","volume":"35","author":"Gontier","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0043","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00259-009-1330-7","article-title":"Clearance of the high intestinal 18FFDG uptake associated with metformin after stopping the drug","volume":"37","author":"\u00d6z\u00fclker","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0044","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.2214\/AJR.10.4663","article-title":"Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin","volume":"195","author":"Oh","year":"2010","journal-title":"AJR"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3413\/nukmed-0190","article-title":"Computer simulations suggest that acute correction of hyperglycaemia with an insulin bolus protocol might be useful in brain FDG PET","volume":"48","author":"Buchert","year":"2009","journal-title":"Nuklearmedizin"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0046","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12149-010-0359-9","article-title":"Normoglycemic plasma glucose levels affect F-18 FDG uptake in the brain","volume":"24","author":"Claeys","year":"2010","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0047","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12149-007-0099-7","article-title":"Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping","volume":"22","author":"Kawasaki","year":"2008","journal-title":"Ann Nucl Med"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2019.06.001_bib0048","first-page":"S55","article-title":"Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging","volume":"10","author":"Femminella","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0049","first-page":"6519","article-title":"Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer's disease protocol for a controlled, randomized double-blinded trial","volume":"59","author":"Egefjord","year":"2012","journal-title":"Dan Med J"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0050","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00259-005-0042-x","article-title":"Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs","volume":"33","author":"Yokoyama","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083758","article-title":"Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia","volume":"9","author":"Gejl","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0052","doi-asserted-by":"crossref","first-page":"E1165","DOI":"10.1210\/jc.2011-3456","article-title":"Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes","volume":"97","author":"Gejl","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0053","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1464-5491.2004.01332.x","article-title":"Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone","volume":"21","author":"H\u00e4llste","year":"2004","journal-title":"Diabet. Med."},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050934","article-title":"Fasting enhances the contrast of bone metastatic lesions in 18F-fluciclovine-PET: Preclinical study using a rat model of mixed osteolytic\/osteoblastic bone metastases","volume":"18","author":"Oka","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00004728-198703000-00002","article-title":"PET study of methionine accumulation in glioma and normal brain tissue: Competition with branched chain amino acids","volume":"11","author":"Bergstrom","year":"1987","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0056","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1148\/radiology.190.3.8115641","article-title":"Head and neck cancer: Effect of food ingestion on uptake of C-11 methionine","volume":"190","author":"Lindholm","year":"1994","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0057","doi-asserted-by":"crossref","first-page":"E1011","DOI":"10.1152\/ajpendo.00690.2009","article-title":"An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle","volume":"298","author":"Drummond","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0085","doi-asserted-by":"crossref","first-page":"e00238","DOI":"10.1002\/phy2.238","article-title":"Insulin increases mRNA abundance of the amino acid transporter SLC7A5\/LAT1 via an mTORC1-dependent mechanism in skeletal muscle cells","volume":"2","author":"Walker","year":"2014","journal-title":"Physiol Rep"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0058","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","article-title":"Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: Version 1.0","volume":"46","author":"Law","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0059","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12933-016-0340-6","article-title":"Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: An imaging study with positron emission tomography tracer 18F-fluoromethylcholine","volume":"15","author":"Helberg","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0060","first-page":"473","article-title":"Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents","volume":"3","author":"Prendergast","year":"1984","journal-title":"Clin Pharm"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0061","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2337\/dc14-3091","article-title":"Hyperglycemia potentiates the slowing of gastric emptying iinduced by exopgenous GLP-1","volume":"38","author":"Plummer","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0062","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1210\/jc.2017-00051","article-title":"Antecedent hypoglycemia does not attenuate the acceleration of gastric emptying by hypoglycemia","volume":"102","author":"Kar","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0063","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cgh.2015.11.021","article-title":"Perspectives in clinical gastroenterology and hepatology: Relationship between control of glycemia and gastric emptying disturbances in diabetes mellitus","volume":"14","author":"Halland","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0064","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02090069","article-title":"Inter and intra subject variability of solid and liquid gastric emptying parameters: A scintigraphic study in healthy subjects and diabetic patients","volume":"39","author":"Lartigue","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0065","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2005-0513","article-title":"Insulin-induced hypolglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes","volume":"90","author":"Russo","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0066","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1463-1326.2007.00737.x","article-title":"Glucose homeostsis and the gastrointestinal tract: insights into the treatment of diabetes","volume":"10","author":"Maggs","year":"2007","journal-title":"Diabetes, Obes Metab"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0067","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2337\/diacare.24.2.371","article-title":"Relationships of upper gastrointestinal motor and senosory function with glycemic control","volume":"24","author":"Rayner","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0068","doi-asserted-by":"crossref","first-page":"E671","DOI":"10.1152\/ajpendo.00492.2002","article-title":"Glucagon and regulation of glucose metabolism","volume":"284","author":"Jiang","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0069","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1152\/ajpendo.00545.2003","article-title":"Role of incretin hormones in regulation of insulin secretion in diabetic and non diabetic humans","volume":"287","author":"Holst","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0070","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0016-5085(88)90248-X","article-title":"Serum glucose concentration as a modulator of interdigestive gastric motility","volume":"94","author":"Barnett","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0071","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0016-5085(83)80232-7","article-title":"Regulation of the gastric emptying of glucose","volume":"85","author":"Brener","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0072","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/BF00400362","article-title":"Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects","volume":"36","author":"Horowitz","year":"1993","journal-title":"Diabetologia"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0073","first-page":"2220","article-title":"Relationships between gastric emptying, intragastricmeal distribution and blood glucose concentrationsin diabetes mellitus","volume":"36","author":"Jones","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0074","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF00400569","article-title":"Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus","volume":"33","author":"Fraser","year":"1990","journal-title":"Diabetologia"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0016-5085(97)70080-5","article-title":"Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus","volume":"113","author":"Schvarcz","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0076","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/gut.37.1.23","article-title":"Highly variable gastric emptying in patients with insulin dependent diabetes mellitus","volume":"37","author":"Nowak","year":"1995","journal-title":"Gut"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0077","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00265086","article-title":"Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus","volume":"32","author":"Horowitz","year":"1989","journal-title":"Diabetologia"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0078","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2005-0513","article-title":"Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes","volume":"90","author":"Russo","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0079","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cgh.2014.06.034","article-title":"Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes","volume":"13","author":"Bharucha","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0081","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s10620-011-1810-z","article-title":"Continuous glucose monitoring in gastroparesis","volume":"56","author":"Ramzan","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0082","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2967\/jnmt.109.067843","article-title":"Procedure guideline for adult solid-meal gastric-emptying study 3.0","volume":"37","author":"Donohoe","year":"2009","journal-title":"J Nucl Med Technol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0083","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2012.373","article-title":"Clinical guideline: Management of gastroparesis","volume":"108","author":"Camilleri","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2019.06.001_bib0084","first-page":"1174","article-title":"Guidelines for insulin dosing in continuous subcutaneous insulin and guidelines for basal-bolus dosing","volume":"4","author":"Davidson","year":"2010","journal-title":"J Diabetes Sci Technol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299819300509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299819300509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:36:03Z","timestamp":1757543763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299819300509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0001299819300509"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2019.06.001","relation":{},"ISSN":["0001-2998"],"issn-type":[{"type":"print","value":"0001-2998"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Serum Glucose and Metabolic Management of Clinical Nuclear Medicine Studies: Current Status and Proposed Future Directions","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}